Laser-capture microdissection of oropharyngeal epithelium indicates restriction of Epstein-Barr virus receptor/CD21 mRNA to tonsil epithelial cells

Journal of Oral Pathology and Medicine

Volumn 37, Issue 10, 2008, Pages 626-633

  Jiang, Ru ^a   Gu, Xin ^b   Nathan, Cherie Ann ^a,b   Hutt Fletcher, Lindsey ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

CD21; Epithelial cells; Epstein Barr virus; Oropharynx

Indexed keywords

COMPLEMENT COMPONENT C3D RECEPTOR; FORMALDEHYDE; MESSENGER RNA;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BAY REGION BINDING SITE; CELL ISOLATION; CHEEK MUCOSA; CONTROLLED STUDY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; EXON; FLOW CYTOMETRY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; LASER CAPTURE MICRODISSECTION; LYMPH NODE; NUCLEOTIDE SEQUENCE; OROPHARYNX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOFT PALATE; TISSUE SECTION; TONGUE; TONSIL; VIRUS ATTACHMENT; VIRUS INFECTION;

B-LYMPHOCYTES; CACO-2 CELLS; EPITHELIAL CELLS; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; LASERS; MICRODISSECTION; PALATINE TONSIL; POLYMERASE CHAIN REACTION; RECEPTORS, COMPLEMENT 3D; RNA, MESSENGER; VIRAL ENVELOPE PROTEINS;

EID: 53549104425     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2008.00681.x     Document Type: Article

References (53)

1. Rickinson AB, Kieff E. Epstein-Barr virus. In : Knipe DM, Howley PM, eds. Fields virology, 5th edn, Vol. 2. Philadelphia : Lippincott Williams & Wilkins, 2007 2655 700.
2. Thorley-Lawson DA, Gross A. Persistence of Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 2004 350 : 1328 37.
3. Laichalk LL, Hochberg D, Babcock GJ, Freeman RB, Thorley-Lawson DA. The dispersal of mucosal memory cells: evidence from persistent EBV infection. Immunity 2002 16 : 745 54.
4. Hochberg D, Middledorp JM, Catalina M, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc Natl Acad Sci USA 2004 101 : 239 44.
5. Crawford DH, Ando I. EB virus induction is associated with B-cell maturation. Immunology 1986 59 : 405 9.
6. Niedobitek G, Aagathanggelou A, Herbst H, Whitehead L, Wright DH, Young LS. Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency, replication and phenotype of infected cells. J Pathol 1997 182 : 151 9.
7. Laichalk LL, Thorley-Lawson DA. Terminal differentiation into plasma cells initiated the replicative cycle of Epstein-Barr virus in vivo. J Virol 2005 79 : 1296 307.
8. Jiang R, Scott RS, Hutt-Fletcher LM. Epstein-Barr virus shed in saliva is high in B cell tropic gp42. J Virol 2006 80 : 7281 3.
9. Pegtel DM, Middeldorp J, Thorley-Lawson DA. Epstein-Barr virus infection in ex-vivo tonsil epithelial cell cultures of asymptomatic carriers. J Virol 2004 78 : 12613 24.
10. Hudnall SD, Ge Y, Wei L, Yang N-P, Wang H-Q, Chen T. Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils. Mod Pathol 2005 18 : 519 27.
11. Hutt-Fletcher LM. Epstein-Barr virus entry. J Virol 2007 81 : 7825 32.
12. Tugizov SM, Berline JW, Palefsky JM. Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nat Med 2003 9 : 307 14.
13. Borza CM, Morgan AJ, Turk SM, Hutt-Fletcher LM. Use of gHgL for attachment of Epstein-Barr virus to epithelial cells compromises infection. J Virol 2004 78 : 5007 14.
14. Molesworth SJ, Lake CM, Borza CM, Turk SM, Hutt-Fletcher LM. Epstein-Barr virus gH is essential for penetration of B cell but also plays a role in attachment of virus to epithelial cells. J Virol 2000 74 : 6324 32.
15. Oda T, Imai S, Chiba S, Takada K. Epstein-Barr virus lacking glycoprotein gp85 cannot infect B cells and epithelial cells. Virology 2000 276 : 52 8.
16. Sixbey JW, Yao Q-Y. Immunoglobulin A-induced shift of Epstein-barr virus tissue tropism. Science 1992 255 : 1578 80.
17. Li QX, Young LS, Niedobitek G, et al. Epstein-Barr virus infection and replication in a human epithelial system. Nature 1992 356 : 347 50.
18. Fingeroth JD, Diamond ME, Sage DR, Hayman J, Yates JL. CD-21 dependent infection of an epithelial cell line, 293, by Epstein-Barr virus. J Virol 1999 73 : 2115 25.
19. Birkenbach M, Tong X, Bradbury LE, Tedder TF, Kieff E. Characterization of an Epstein-Barr virus receptor on human epithelial cells. J Exp Med 1992 176 : 1405 14.
20. Levine J, Pflugfelder SC, Yen M, Crouse CA, Atherton SS. Detection of the complement (CD21)/Epstein-Barr virus receptor in human lacrimal gland and ocular surface epithelia. Reg Immunol 1990 1991 3 : 164 70.
21. Sixbey JW, Davis DS, Young LS, Hutt-Fletcher L, Tedder TF, Rickinson AB. Human epithelial cell expression of an Epstein-Barr virus receptor. J Gen Virol 1987 68 : 805 11.
22. Timens W, Boes A, Vos H, Poppema S. Tissue distribution of the C3d/EBV-receptor: CD21 monoclonal antibodies reactive with a variety of epithelial cells, medullary thymocytes, and peripheral T cells. Histochemistry 1991 95 : 605 11.
23. Talacko AA, Teo CG, Griffin BE, Johnson NW. Epstein-Barr virus receptors but not viral DNA are present in normal and malignant oral epithelium. J Oral Pathol Med 1991 20 : 20 5.
24. Thomas JA, Crawford DH. Epstein-Barr virus/complement receptor and epithelial cells. Lancet 1989 2 : 449 50.
25. Young LS, Clark D, Sixbey JW, Rickinson AB. Epstein-Barr virus receptors on human pharyngeal epithelium. Lancet 1986 1 : 240 2.
26. Young LS, Dawson CW, Brown KW, Rickinson AB. Identification of a human epithelial cell surface protein sharing an epitope with the C3d/Epstein-Barr virus receptor molecule of B lymphocytes. Int J Cancer 1989 43 : 786 94.
27. Niedobitek G, Herbst H, Stein H. Epstein-Barr virus/complement receptor and epithelial cells. Lancet 1989 2 : 110.
28. Weis JJ, Toothaker LE, Smith JA, Weis JH, Fearon DT. Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins. J Exp Med 1988 167 : 1047 66.
29. Martin DR, Yuryev A, Kalli KR, Fearon DT, Ahearn JM. Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2. J Exp Med 1991 174 : 1299 311.
30. Fujisaku A, Harley JB, Frank MB, Gruner BA, Frazier B, Holers VM. Genomic organization and polymorphisms of the human C3d/Epstein-Barr virus receptor. J Biol Chem 1989 264 : 2118 25.
31. Borza C, Hutt-Fletcher LM. Epstein-Barr virus recombinant lacking expression of glycoprotein gp150 infects B cells normally but is enhanced for infection of the epithelial line SVKCR2. J Virol 1998 72 : 7577 82.
32. Nemerow GR, Wolfert R, Mcnaughton M, Cooper NR. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J Virol 1985 55 : 347 51.
33. Petzer AL, Schulz TF, Stauder R, Eogentler A, Myones BL, Dierich MP. Structural and functional analysis of CR2/EBV receptor by means of monoclonal antibodies and tryptic digestion. Immunology 1988 63 : 47 53.
34. Weis JJ, Tedder TF, Fearon DT. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc Natl Acad Sci USA 1984 81 : 881 5.
35. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCt method. Methods 2001 25 : 402 8.
36. Yoshiyama H, Imai S, Shimizu N, Takada K. Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21. J Virol 1997 71 : 5688 91.
37. Lowell CA, Klickenstein LB, Carter RH, Mitchell JA, Fearon DT, Ahearn JM. Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2. J Exp Med 1989 170 : 1931 46.
38. Carel J-C, Myones BL, Frazier B, Holers VM. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection. J Biol Chem 1990 265 : 12293 9.
39. Fischer E, Delibrias C, Kazatchkine MD. Expression of CR2 (the C3dg/EBV receptor) on normal human peripheral blood T lymphocytes. J Immunol 1991 146 : 865 9.
40. Fingeroth JD, Clabby ML, Strominger JD. Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21). J Virol 1988 62 : 1442 7.
41. Van Nierop K, De Groot C. Human follicular dendritic cells: function, origin and development. Semin Immunol 2002 14 : 251 7.
42. Lemon SM, Hutt LM, Shaw JE, Li JL, Pagano JS. Replication of EBV in epithelial cells during infectious mononucleosis. Nature 1977 268 : 268 70.
43. Sixbey JW, Vesterinen EH, Nedrud JG, Raab-Traub N, Walton LA, Pagano JS. Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature 1983 306 : 480 3.
44. Sixbey JW, Lemon SM, Pagano JS. A second site for Epstein-Barr virus shedding: the uterine cervix. Lancet 1986 2 : 1122 4.
45. Anagnastopoulos IMH, Kreschel C, Stein H. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 1995 85 : 744 50.
46. Karjannis MA, Hummel M, Anagnostopoulos I, Stein H. Strict lymphotropism of Epstein-Barr virus during acute infectious mononucleosis in nonimmunocompromised individuals. Blood 1997 89 : 2856 62.
47. Niedobitek G, Hamilton-Dutoit S, Herbst H, et al. Identification of Epstein-Barr virus-infected cells in tonsils of acute infectious mononucleosis by in situ hybridization. Hum Pathol 1989 20 : 796 9.
48. Tao Q, Srivastava G, Chan ACL, Chung LP, Loke SL, Ho FC. Evidence for lytic infection by Epstein-Barr virus in mucosal lymphocytes instead of nasopharyngeal epithelial cells in normal individuals. J Med Virol 1995 45 : 71 7.
49. Feederle R, Neuhierl B, Bannert H, Geletneky K, Shannon-Lowe CD, Delecluse HJ. Epstein-Barr virus B95.8 produced in 293 cells shows marked tropism for differentiated primary epithelial cells and reveals interindividual variation in susceptibility to viral infection. Int J Cancer 2006 121 : 588 94.
50. Shannon-Lowe CD, Neuhierl B, Baldwin G, Rickinson AB, Delecluse H-J. Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci USA 2006 103 : 7065 70.
51. Webster-Cyriaque J, Raab-Traub N. Transcription of Epstein-Barr virus latent cycle genes in oral hairy leukoplakia. Virology 1998 248 : 53 65.
52. Chan ASC, To KF, Lo KW, et al. Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese. Int J Cancer 2002 102 : 300 3.
53. Chan ASC, To KF, Lo KW, et al. High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from Southern Chinese. Cancer Res 2000 60 : 5365 70.